Propolis: Antineoplastic Activity, Constituents, and Mechanisms of Action. 2023

Patricia Ruiz-Bustos, and Efrain Alday, and Adriana Garibay-Escobar, and José Maurício Sforcin, and Yulia Lipovka, and Javier Hernandez, and Carlos Velazquez
Department of Chemistry-Biology, University of Sonora, Blvd. Luis Encinas y Rosales s/n, 83000, Son., Mexico.

Propolis is a beehive product with great pharmacological potential, including antineoplastic activity. OBJECTIVE The aim of this study is to provide an actual understanding of the existent scientific information regarding the antiproliferative effect of propolis, proposed mechanisms of action, and challenges to meet. METHODS An assessment of the scientific literature was attained using the PubMed and SciFinder platforms. Research papers, clinical trials, and reviews published between the years 2000 - 2021, were considered. The words "anticancer", "antitumor", "antiproliferative" and "propolis" were used in the search criteria. CONCLUSIONS A summary of several antiproliferative activities of different types of propolis is exposed. The potential health benefits of propolis are discussed. The variable plant origin of propolis partially accounts for its anti-cancer activities. Even when some mechanisms of action of propolis have been proposed, much of the genesis of how this effect is produced is yet to be answered, including several molecular mechanisms in different biological systems.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011429 Propolis A resinous substance obtained from beehives that is used traditionally as an antimicrobial. It is a heterogeneous mixture of many substances. Bee Bread,Bee Glue,Bread, Bee,Glue, Bee
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

Patricia Ruiz-Bustos, and Efrain Alday, and Adriana Garibay-Escobar, and José Maurício Sforcin, and Yulia Lipovka, and Javier Hernandez, and Carlos Velazquez
January 1979, Die Pharmazie,
Patricia Ruiz-Bustos, and Efrain Alday, and Adriana Garibay-Escobar, and José Maurício Sforcin, and Yulia Lipovka, and Javier Hernandez, and Carlos Velazquez
July 2018, Anti-cancer drugs,
Patricia Ruiz-Bustos, and Efrain Alday, and Adriana Garibay-Escobar, and José Maurício Sforcin, and Yulia Lipovka, and Javier Hernandez, and Carlos Velazquez
July 2019, Chemistry & biodiversity,
Patricia Ruiz-Bustos, and Efrain Alday, and Adriana Garibay-Escobar, and José Maurício Sforcin, and Yulia Lipovka, and Javier Hernandez, and Carlos Velazquez
April 2006, Fitoterapia,
Patricia Ruiz-Bustos, and Efrain Alday, and Adriana Garibay-Escobar, and José Maurício Sforcin, and Yulia Lipovka, and Javier Hernandez, and Carlos Velazquez
February 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Patricia Ruiz-Bustos, and Efrain Alday, and Adriana Garibay-Escobar, and José Maurício Sforcin, and Yulia Lipovka, and Javier Hernandez, and Carlos Velazquez
December 1979, Die Pharmazie,
Patricia Ruiz-Bustos, and Efrain Alday, and Adriana Garibay-Escobar, and José Maurício Sforcin, and Yulia Lipovka, and Javier Hernandez, and Carlos Velazquez
April 1998, Seminars in oncology,
Patricia Ruiz-Bustos, and Efrain Alday, and Adriana Garibay-Escobar, and José Maurício Sforcin, and Yulia Lipovka, and Javier Hernandez, and Carlos Velazquez
January 2008, Metal-based drugs,
Patricia Ruiz-Bustos, and Efrain Alday, and Adriana Garibay-Escobar, and José Maurício Sforcin, and Yulia Lipovka, and Javier Hernandez, and Carlos Velazquez
December 2009, Biological & pharmaceutical bulletin,
Patricia Ruiz-Bustos, and Efrain Alday, and Adriana Garibay-Escobar, and José Maurício Sforcin, and Yulia Lipovka, and Javier Hernandez, and Carlos Velazquez
May 2008, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!